カテゴリー： Market Monitor Global, 世界, 医療/バイオ

免疫グロブリン静注の世界市場見通し2023年-2029年

◆英語タイトル：Immune Globulin Intravenous Market, Global Outlook and Forecast 2023-2029
	◆商品コード：MMG23LY8803 ◆発行会社（リサーチ会社）：Market Monitor Global ◆発行日：2023年7月 ◆ページ数：73 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医薬品＆ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Immune Globulin Intravenous Market 調査レポートは次の情報を含め、グローバルにおけるの免疫グロブリン静注市場規模と予測を収録しています。・世界の免疫グロブリン静注市場：売上、2018年-2023年、2024年-2029年
・世界の免疫グロブリン静注市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の免疫グロブリン静注市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「IVIg液」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

免疫グロブリン静注のグローバル主要企業は、Takeda、 Grifols、 CSL、 Octapharma、 Biotest、 Kedrion、 Hualan Bio、 CNBG、 Shanghai RAAS、 CBPO、 LFB Group、 BPL、 Sichuan Yuanda Shuyangなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、免疫グロブリン静注のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の免疫グロブリン静注市場：タイプ別、2018年-2023年、2024年-2029年
世界の免疫グロブリン静注市場：タイプ別市場シェア、2022年
・IVIg液、IVIg粉末

世界の免疫グロブリン静注市場：用途別、2018年-2023年、2024年-2029年
世界の免疫グロブリン静注市場：用途別市場シェア、2022年
・免疫不全、自己免疫疾患、急性感染症

世界の免疫グロブリン静注市場：地域・国別、2018年-2023年、2024年-2029年
世界の免疫グロブリン静注市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における免疫グロブリン静注のグローバル売上、2018年-2023年
・主要企業における免疫グロブリン静注のグローバル売上シェア、2022年
・主要企業における免疫グロブリン静注のグローバル販売量、2018年-2023年
・主要企業における免疫グロブリン静注のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Takeda、 Grifols、 CSL、 Octapharma、 Biotest、 Kedrion、 Hualan Bio、 CNBG、 Shanghai RAAS、 CBPO、 LFB Group、 BPL、 Sichuan Yuanda Shuyang

*************************************************************

・調査・分析レポートの概要
免疫グロブリン静注市場の定義
市場セグメント
世界の免疫グロブリン静注市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の免疫グロブリン静注市場規模
世界の免疫グロブリン静注市場規模：2022年 VS 2029年
世界の免疫グロブリン静注市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの免疫グロブリン静注の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の免疫グロブリン静注製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：IVIg液、IVIg粉末
免疫グロブリン静注のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：免疫不全、自己免疫疾患、急性感染症
免疫グロブリン静注の用途別グローバル売上・予測

・地域別市場分析
地域別免疫グロブリン静注市場規模 2022年と2029年
地域別免疫グロブリン静注売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Takeda、 Grifols、 CSL、 Octapharma、 Biotest、 Kedrion、 Hualan Bio、 CNBG、 Shanghai RAAS、 CBPO、 LFB Group、 BPL、 Sichuan Yuanda Shuyang
...

Immune globulin (Ig) short-term protection against hepatitis A and measles
This report aims to provide a comprehensive presentation of the global market for Immune Globulin Intravenous, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immune Globulin Intravenous. This report contains market size and forecasts of Immune Globulin Intravenous in global, including the following market information:
Global Immune Globulin Intravenous Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Immune Globulin Intravenous Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Immune Globulin Intravenous companies in 2022 (%)
The global Immune Globulin Intravenous market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
IVIg Liquid Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Immune Globulin Intravenous include Takeda, Grifols, CSL, Octapharma, Biotest, Kedrion, Hualan Bio, CNBG and Shanghai RAAS, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Immune Globulin Intravenous manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Immune Globulin Intravenous Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Immune Globulin Intravenous Market Segment Percentages, by Type, 2022 (%)
IVIg Liquid
IVIg Powder
Global Immune Globulin Intravenous Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Immune Globulin Intravenous Market Segment Percentages, by Application, 2022 (%)
Immunodeficiency
Autoimmune Disease
Acute Infection
Global Immune Globulin Intravenous Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Immune Globulin Intravenous Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Immune Globulin Intravenous revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Immune Globulin Intravenous revenues share in global market, 2022 (%)
Key companies Immune Globulin Intravenous sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Immune Globulin Intravenous sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Takeda
Grifols
CSL
Octapharma
Biotest
Kedrion
Hualan Bio
CNBG
Shanghai RAAS
CBPO
LFB Group
BPL
Sichuan Yuanda Shuyang
Outline of Major Chapters:
Chapter 1: Introduces the definition of Immune Globulin Intravenous, market overview.
Chapter 2: Global Immune Globulin Intravenous market size in revenue and volume.
Chapter 3: Detailed analysis of Immune Globulin Intravenous manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Immune Globulin Intravenous in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Immune Globulin Intravenous capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Immune Globulin Intravenous Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Immune Globulin Intravenous Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Immune Globulin Intravenous Overall Market Size
2.1 Global Immune Globulin Intravenous Market Size: 2022 VS 2029
2.2 Global Immune Globulin Intravenous Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Immune Globulin Intravenous Sales: 2018-2029
3 Company Landscape
3.1 Top Immune Globulin Intravenous Players in Global Market
3.2 Top Global Immune Globulin Intravenous Companies Ranked by Revenue
3.3 Global Immune Globulin Intravenous Revenue by Companies
3.4 Global Immune Globulin Intravenous Sales by Companies
3.5 Global Immune Globulin Intravenous Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Immune Globulin Intravenous Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Immune Globulin Intravenous Product Type
3.8 Tier 1, Tier 2 and Tier 3 Immune Globulin Intravenous Players in Global Market
3.8.1 List of Global Tier 1 Immune Globulin Intravenous Companies
3.8.2 List of Global Tier 2 and Tier 3 Immune Globulin Intravenous Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Immune Globulin Intravenous Market Size Markets, 2022 & 2029
4.1.2 IVIg Liquid
4.1.3 IVIg Powder
4.2 By Type – Global Immune Globulin Intravenous Revenue & Forecasts
4.2.1 By Type – Global Immune Globulin Intravenous Revenue, 2018-2023
4.2.2 By Type – Global Immune Globulin Intravenous Revenue, 2024-2029
4.2.3 By Type – Global Immune Globulin Intravenous Revenue Market Share, 2018-2029
4.3 By Type – Global Immune Globulin Intravenous Sales & Forecasts
4.3.1 By Type – Global Immune Globulin Intravenous Sales, 2018-2023
4.3.2 By Type – Global Immune Globulin Intravenous Sales, 2024-2029
4.3.3 By Type – Global Immune Globulin Intravenous Sales Market Share, 2018-2029
4.4 By Type – Global Immune Globulin Intravenous Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Immune Globulin Intravenous Market Size, 2022 & 2029
5.1.2 Immunodeficiency
5.1.3 Autoimmune Disease
5.1.4 Acute Infection
5.2 By Application – Global Immune Globulin Intravenous Revenue & Forecasts
5.2.1 By Application – Global Immune Globulin Intravenous Revenue, 2018-2023
5.2.2 By Application – Global Immune Globulin Intravenous Revenue, 2024-2029
5.2.3 By Application – Global Immune Globulin Intravenous Revenue Market Share, 2018-2029
5.3 By Application – Global Immune Globulin Intravenous Sales & Forecasts
5.3.1 By Application – Global Immune Globulin Intravenous Sales, 2018-2023
5.3.2 By Application – Global Immune Globulin Intravenous Sales, 2024-2029
5.3.3 By Application – Global Immune Globulin Intravenous Sales Market Share, 2018-2029
5.4 By Application – Global Immune Globulin Intravenous Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Immune Globulin Intravenous Market Size, 2022 & 2029
6.2 By Region – Global Immune Globulin Intravenous Revenue & Forecasts
6.2.1 By Region – Global Immune Globulin Intravenous Revenue, 2018-2023
6.2.2 By Region – Global Immune Globulin Intravenous Revenue, 2024-2029
6.2.3 By Region – Global Immune Globulin Intravenous Revenue Market Share, 2018-2029
6.3 By Region – Global Immune Globulin Intravenous Sales & Forecasts
6.3.1 By Region – Global Immune Globulin Intravenous Sales, 2018-2023
6.3.2 By Region – Global Immune Globulin Intravenous Sales, 2024-2029
6.3.3 By Region – Global Immune Globulin Intravenous Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Immune Globulin Intravenous Revenue, 2018-2029
6.4.2 By Country – North America Immune Globulin Intravenous Sales, 2018-2029
6.4.3 US Immune Globulin Intravenous Market Size, 2018-2029
6.4.4 Canada Immune Globulin Intravenous Market Size, 2018-2029
6.4.5 Mexico Immune Globulin Intravenous Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Immune Globulin Intravenous Revenue, 2018-2029
6.5.2 By Country – Europe Immune Globulin Intravenous Sales, 2018-2029
6.5.3 Germany Immune Globulin Intravenous Market Size, 2018-2029
6.5.4 France Immune Globulin Intravenous Market Size, 2018-2029
6.5.5 U.K. Immune Globulin Intravenous Market Size, 2018-2029
6.5.6 Italy Immune Globulin Intravenous Market Size, 2018-2029
6.5.7 Russia Immune Globulin Intravenous Market Size, 2018-2029
6.5.8 Nordic Countries Immune Globulin Intravenous Market Size, 2018-2029
6.5.9 Benelux Immune Globulin Intravenous Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Immune Globulin Intravenous Revenue, 2018-2029
6.6.2 By Region – Asia Immune Globulin Intravenous Sales, 2018-2029
6.6.3 China Immune Globulin Intravenous Market Size, 2018-2029
6.6.4 Japan Immune Globulin Intravenous Market Size, 2018-2029
6.6.5 South Korea Immune Globulin Intravenous Market Size, 2018-2029
6.6.6 Southeast Asia Immune Globulin Intravenous Market Size, 2018-2029
6.6.7 India Immune Globulin Intravenous Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Immune Globulin Intravenous Revenue, 2018-2029
6.7.2 By Country – South America Immune Globulin Intravenous Sales, 2018-2029
6.7.3 Brazil Immune Globulin Intravenous Market Size, 2018-2029
6.7.4 Argentina Immune Globulin Intravenous Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Immune Globulin Intravenous Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Immune Globulin Intravenous Sales, 2018-2029
6.8.3 Turkey Immune Globulin Intravenous Market Size, 2018-2029
6.8.4 Israel Immune Globulin Intravenous Market Size, 2018-2029
6.8.5 Saudi Arabia Immune Globulin Intravenous Market Size, 2018-2029
6.8.6 UAE Immune Globulin Intravenous Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Takeda
7.1.1 Takeda Company Summary
7.1.2 Takeda Business Overview
7.1.3 Takeda Immune Globulin Intravenous Major Product Offerings
7.1.4 Takeda Immune Globulin Intravenous Sales and Revenue in Global (2018-2023)
7.1.5 Takeda Key News & Latest Developments
7.2 Grifols
7.2.1 Grifols Company Summary
7.2.2 Grifols Business Overview
7.2.3 Grifols Immune Globulin Intravenous Major Product Offerings
7.2.4 Grifols Immune Globulin Intravenous Sales and Revenue in Global (2018-2023)
7.2.5 Grifols Key News & Latest Developments
7.3 CSL
7.3.1 CSL Company Summary
7.3.2 CSL Business Overview
7.3.3 CSL Immune Globulin Intravenous Major Product Offerings
7.3.4 CSL Immune Globulin Intravenous Sales and Revenue in Global (2018-2023)
7.3.5 CSL Key News & Latest Developments
7.4 Octapharma
7.4.1 Octapharma Company Summary
7.4.2 Octapharma Business Overview
7.4.3 Octapharma Immune Globulin Intravenous Major Product Offerings
7.4.4 Octapharma Immune Globulin Intravenous Sales and Revenue in Global (2018-2023)
7.4.5 Octapharma Key News & Latest Developments
7.5 Biotest
7.5.1 Biotest Company Summary
7.5.2 Biotest Business Overview
7.5.3 Biotest Immune Globulin Intravenous Major Product Offerings
7.5.4 Biotest Immune Globulin Intravenous Sales and Revenue in Global (2018-2023)
7.5.5 Biotest Key News & Latest Developments
7.6 Kedrion
7.6.1 Kedrion Company Summary
7.6.2 Kedrion Business Overview
7.6.3 Kedrion Immune Globulin Intravenous Major Product Offerings
7.6.4 Kedrion Immune Globulin Intravenous Sales and Revenue in Global (2018-2023)
7.6.5 Kedrion Key News & Latest Developments
7.7 Hualan Bio
7.7.1 Hualan Bio Company Summary
7.7.2 Hualan Bio Business Overview
7.7.3 Hualan Bio Immune Globulin Intravenous Major Product Offerings
7.7.4 Hualan Bio Immune Globulin Intravenous Sales and Revenue in Global (2018-2023)
7.7.5 Hualan Bio Key News & Latest Developments
7.8 CNBG
7.8.1 CNBG Company Summary
7.8.2 CNBG Business Overview
7.8.3 CNBG Immune Globulin Intravenous Major Product Offerings
7.8.4 CNBG Immune Globulin Intravenous Sales and Revenue in Global (2018-2023)
7.8.5 CNBG Key News & Latest Developments
7.9 Shanghai RAAS
7.9.1 Shanghai RAAS Company Summary
7.9.2 Shanghai RAAS Business Overview
7.9.3 Shanghai RAAS Immune Globulin Intravenous Major Product Offerings
7.9.4 Shanghai RAAS Immune Globulin Intravenous Sales and Revenue in Global (2018-2023)
7.9.5 Shanghai RAAS Key News & Latest Developments
7.10 CBPO
7.10.1 CBPO Company Summary
7.10.2 CBPO Business Overview
7.10.3 CBPO Immune Globulin Intravenous Major Product Offerings
7.10.4 CBPO Immune Globulin Intravenous Sales and Revenue in Global (2018-2023)
7.10.5 CBPO Key News & Latest Developments
7.11 LFB Group
7.11.1 LFB Group Company Summary
7.11.2 LFB Group Immune Globulin Intravenous Business Overview
7.11.3 LFB Group Immune Globulin Intravenous Major Product Offerings
7.11.4 LFB Group Immune Globulin Intravenous Sales and Revenue in Global (2018-2023)
7.11.5 LFB Group Key News & Latest Developments
7.12 BPL
7.12.1 BPL Company Summary
7.12.2 BPL Immune Globulin Intravenous Business Overview
7.12.3 BPL Immune Globulin Intravenous Major Product Offerings
7.12.4 BPL Immune Globulin Intravenous Sales and Revenue in Global (2018-2023)
7.12.5 BPL Key News & Latest Developments
7.13 Sichuan Yuanda Shuyang
7.13.1 Sichuan Yuanda Shuyang Company Summary
7.13.2 Sichuan Yuanda Shuyang Immune Globulin Intravenous Business Overview
7.13.3 Sichuan Yuanda Shuyang Immune Globulin Intravenous Major Product Offerings
7.13.4 Sichuan Yuanda Shuyang Immune Globulin Intravenous Sales and Revenue in Global (2018-2023)
7.13.5 Sichuan Yuanda Shuyang Key News & Latest Developments
8 Global Immune Globulin Intravenous Production Capacity, Analysis
8.1 Global Immune Globulin Intravenous Production Capacity, 2018-2029
8.2 Immune Globulin Intravenous Production Capacity of Key Manufacturers in Global Market
8.3 Global Immune Globulin Intravenous Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Immune Globulin Intravenous Supply Chain Analysis
10.1 Immune Globulin Intravenous Industry Value Chain
10.2 Immune Globulin Intravenous Upstream Market
10.3 Immune Globulin Intravenous Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Immune Globulin Intravenous Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Immune Globulin Intravenous in Global Market
Table 2. Top Immune Globulin Intravenous Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Immune Globulin Intravenous Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Immune Globulin Intravenous Revenue Share by Companies, 2018-2023
Table 5. Global Immune Globulin Intravenous Sales by Companies, (K Units), 2018-2023
Table 6. Global Immune Globulin Intravenous Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Immune Globulin Intravenous Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Immune Globulin Intravenous Product Type
Table 9. List of Global Tier 1 Immune Globulin Intravenous Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Immune Globulin Intravenous Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Immune Globulin Intravenous Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Immune Globulin Intravenous Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Immune Globulin Intravenous Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Immune Globulin Intravenous Sales (K Units), 2018-2023
Table 15. By Type - Global Immune Globulin Intravenous Sales (K Units), 2024-2029
Table 16. By Application – Global Immune Globulin Intravenous Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Immune Globulin Intravenous Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Immune Globulin Intravenous Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Immune Globulin Intravenous Sales (K Units), 2018-2023
Table 20. By Application - Global Immune Globulin Intravenous Sales (K Units), 2024-2029
Table 21. By Region – Global Immune Globulin Intravenous Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Immune Globulin Intravenous Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Immune Globulin Intravenous Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Immune Globulin Intravenous Sales (K Units), 2018-2023
Table 25. By Region - Global Immune Globulin Intravenous Sales (K Units), 2024-2029
Table 26. By Country - North America Immune Globulin Intravenous Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Immune Globulin Intravenous Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Immune Globulin Intravenous Sales, (K Units), 2018-2023
Table 29. By Country - North America Immune Globulin Intravenous Sales, (K Units), 2024-2029
Table 30. By Country - Europe Immune Globulin Intravenous Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Immune Globulin Intravenous Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Immune Globulin Intravenous Sales, (K Units), 2018-2023
Table 33. By Country - Europe Immune Globulin Intravenous Sales, (K Units), 2024-2029
Table 34. By Region - Asia Immune Globulin Intravenous Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Immune Globulin Intravenous Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Immune Globulin Intravenous Sales, (K Units), 2018-2023
Table 37. By Region - Asia Immune Globulin Intravenous Sales, (K Units), 2024-2029
Table 38. By Country - South America Immune Globulin Intravenous Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Immune Globulin Intravenous Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Immune Globulin Intravenous Sales, (K Units), 2018-2023
Table 41. By Country - South America Immune Globulin Intravenous Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Immune Globulin Intravenous Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Immune Globulin Intravenous Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Immune Globulin Intravenous Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Immune Globulin Intravenous Sales, (K Units), 2024-2029
Table 46. Takeda Company Summary
Table 47. Takeda Immune Globulin Intravenous Product Offerings
Table 48. Takeda Immune Globulin Intravenous Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Takeda Key News & Latest Developments
Table 50. Grifols Company Summary
Table 51. Grifols Immune Globulin Intravenous Product Offerings
Table 52. Grifols Immune Globulin Intravenous Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Grifols Key News & Latest Developments
Table 54. CSL Company Summary
Table 55. CSL Immune Globulin Intravenous Product Offerings
Table 56. CSL Immune Globulin Intravenous Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. CSL Key News & Latest Developments
Table 58. Octapharma Company Summary
Table 59. Octapharma Immune Globulin Intravenous Product Offerings
Table 60. Octapharma Immune Globulin Intravenous Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Octapharma Key News & Latest Developments
Table 62. Biotest Company Summary
Table 63. Biotest Immune Globulin Intravenous Product Offerings
Table 64. Biotest Immune Globulin Intravenous Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Biotest Key News & Latest Developments
Table 66. Kedrion Company Summary
Table 67. Kedrion Immune Globulin Intravenous Product Offerings
Table 68. Kedrion Immune Globulin Intravenous Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Kedrion Key News & Latest Developments
Table 70. Hualan Bio Company Summary
Table 71. Hualan Bio Immune Globulin Intravenous Product Offerings
Table 72. Hualan Bio Immune Globulin Intravenous Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Hualan Bio Key News & Latest Developments
Table 74. CNBG Company Summary
Table 75. CNBG Immune Globulin Intravenous Product Offerings
Table 76. CNBG Immune Globulin Intravenous Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. CNBG Key News & Latest Developments
Table 78. Shanghai RAAS Company Summary
Table 79. Shanghai RAAS Immune Globulin Intravenous Product Offerings
Table 80. Shanghai RAAS Immune Globulin Intravenous Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. Shanghai RAAS Key News & Latest Developments
Table 82. CBPO Company Summary
Table 83. CBPO Immune Globulin Intravenous Product Offerings
Table 84. CBPO Immune Globulin Intravenous Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 85. CBPO Key News & Latest Developments
Table 86. LFB Group Company Summary
Table 87. LFB Group Immune Globulin Intravenous Product Offerings
Table 88. LFB Group Immune Globulin Intravenous Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 89. LFB Group Key News & Latest Developments
Table 90. BPL Company Summary
Table 91. BPL Immune Globulin Intravenous Product Offerings
Table 92. BPL Immune Globulin Intravenous Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 93. BPL Key News & Latest Developments
Table 94. Sichuan Yuanda Shuyang Company Summary
Table 95. Sichuan Yuanda Shuyang Immune Globulin Intravenous Product Offerings
Table 96. Sichuan Yuanda Shuyang Immune Globulin Intravenous Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 97. Sichuan Yuanda Shuyang Key News & Latest Developments
Table 98. Immune Globulin Intravenous Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 99. Global Immune Globulin Intravenous Capacity Market Share of Key Manufacturers, 2021-2023
Table 100. Global Immune Globulin Intravenous Production by Region, 2018-2023 (K Units)
Table 101. Global Immune Globulin Intravenous Production by Region, 2024-2029 (K Units)
Table 102. Immune Globulin Intravenous Market Opportunities & Trends in Global Market
Table 103. Immune Globulin Intravenous Market Drivers in Global Market
Table 104. Immune Globulin Intravenous Market Restraints in Global Market
Table 105. Immune Globulin Intravenous Raw Materials
Table 106. Immune Globulin Intravenous Raw Materials Suppliers in Global Market
Table 107. Typical Immune Globulin Intravenous Downstream
Table 108. Immune Globulin Intravenous Downstream Clients in Global Market
Table 109. Immune Globulin Intravenous Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Immune Globulin Intravenous Segment by Type in 2022
Figure 2. Immune Globulin Intravenous Segment by Application in 2022
Figure 3. Global Immune Globulin Intravenous Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Immune Globulin Intravenous Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Immune Globulin Intravenous Revenue, 2018-2029 (US$, Mn)
Figure 7. Immune Globulin Intravenous Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Immune Globulin Intravenous Revenue in 2022
Figure 9. By Type - Global Immune Globulin Intravenous Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Immune Globulin Intravenous Revenue Market Share, 2018-2029
Figure 11. By Type - Global Immune Globulin Intravenous Sales Market Share, 2018-2029
Figure 12. By Type - Global Immune Globulin Intravenous Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Immune Globulin Intravenous Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Immune Globulin Intravenous Revenue Market Share, 2018-2029
Figure 15. By Application - Global Immune Globulin Intravenous Sales Market Share, 2018-2029
Figure 16. By Application - Global Immune Globulin Intravenous Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Immune Globulin Intravenous Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Immune Globulin Intravenous Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Immune Globulin Intravenous Revenue Market Share, 2018-2029
Figure 20. By Region - Global Immune Globulin Intravenous Sales Market Share, 2018-2029
Figure 21. By Country - North America Immune Globulin Intravenous Revenue Market Share, 2018-2029
Figure 22. By Country - North America Immune Globulin Intravenous Sales Market Share, 2018-2029
Figure 23. US Immune Globulin Intravenous Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Immune Globulin Intravenous Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Immune Globulin Intravenous Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Immune Globulin Intravenous Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Immune Globulin Intravenous Sales Market Share, 2018-2029
Figure 28. Germany Immune Globulin Intravenous Revenue, (US$, Mn), 2018-2029
Figure 29. France Immune Globulin Intravenous Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Immune Globulin Intravenous Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Immune Globulin Intravenous Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Immune Globulin Intravenous Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Immune Globulin Intravenous Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Immune Globulin Intravenous Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Immune Globulin Intravenous Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Immune Globulin Intravenous Sales Market Share, 2018-2029
Figure 37. China Immune Globulin Intravenous Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Immune Globulin Intravenous Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Immune Globulin Intravenous Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Immune Globulin Intravenous Revenue, (US$, Mn), 2018-2029
Figure 41. India Immune Globulin Intravenous Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Immune Globulin Intravenous Revenue Market Share, 2018-2029
Figure 43. By Country - South America Immune Globulin Intravenous Sales Market Share, 2018-2029
Figure 44. Brazil Immune Globulin Intravenous Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Immune Globulin Intravenous Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Immune Globulin Intravenous Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Immune Globulin Intravenous Sales Market Share, 2018-2029
Figure 48. Turkey Immune Globulin Intravenous Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Immune Globulin Intravenous Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Immune Globulin Intravenous Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Immune Globulin Intravenous Revenue, (US$, Mn), 2018-2029
Figure 52. Global Immune Globulin Intravenous Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Immune Globulin Intravenous by Region, 2022 VS 2029
Figure 54. Immune Globulin Intravenous Industry Value Chain
Figure 55. Marketing Channels

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 免疫グロブリン静注の世界市場見通し2023年-2029年(Immune Globulin Intravenous Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

免疫グロブリン静注の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp